Kraken's tokenised Ōura IPO offer excludes UK investors

Payward said on 25 September 2026 that eligible customers of Kraken and other members of its xStocks Alliance in more than 110 countries could register non-binding indications of interest for a token called OURAx, tied to the planned Nasdaq listing of sleep-tracking ring maker Oura Inc. The United Kingdom is not one of those countries. Kraken's own product pages list the UK alongside the US, Canada, Australia and, in places, New Zealand and Japan as excluded, with a note that further geographic restrictions may apply.

The exclusion matters to UK readers not because it removes a chance to buy Oura's shares directly — OURAx is a separate tokenised debt security, not the underlying Nasdaq stock itself — but because it is a live, dated example of how this category of product, "tokenised securities", sits awkwardly against UK financial regulation. Oura's pricing and Nasdaq debut were still scheduled, not completed, as of 28 September 2026: pricing was expected on 29 September and listing under the ticker OURA on 30 September. Nothing here should be read as confirming those events happened.

How the offer is meant to work

Oura's amended US registration statement, filed with the Securities and Exchange Commission, covers 50,000,000 common shares — 13,500,000 sold by the company and 36,500,000 by existing shareholders — with an indicated price range of $40.00 to $44.00 per share and an underwriters' option on a further 7,500,000 shares. The filing states that Oura does not expect to pay dividends on its common stock for the foreseeable future.

Payward says it aggregates indications of interest from customers of Kraken and its xStocks Alliance partners, then works with the IPO's underwriting syndicate to try to secure an allocation of shares. Oura and its underwriters decide the outcome, which Payward says may be full, partial or zero. The stated access price during the indication window carried a 5% fee or spread on top of the underlying share price. Customers who receive an allocation are due to get OURAx tokens on listing day, each described as backed 1:1 by an Oura share held in what Payward calls regulated custody. xStocks put the expected post-listing free float at around 15%, and warned that a thin float could add to volatility — an estimate, not an observed trading figure, since trading had not begun as of the research date.

What a holder would actually have

The commercial language around this product is "tokenised equities", but Payward's legal disclosures describe xStocks as tokenised debt securities, issued by a Jersey company, Backed Assets (JE) Limited. Inside the European Economic Area they are offered under an EU-registered prospectus and distributed by a Cyprus-regulated investment firm; outside the EEA, through a Bermuda-regulated Payward entity. That distinction is not a technicality. A debt security issued by Backed Assets (JE) Limited is a different legal claim from a share in Oura Inc.

Kraken is explicit that an xStock does not give the holder ownership of the underlying company share, a vote at Oura's shareholder meetings, a legal claim on Oura's shares or residual assets, or a dividend paid as cash. What it gives is economic exposure to the share price. Kraken also says that where a company does pay a dividend, the net amount is reinvested into the underlying assets and reflected through a change to a token multiplier or balance — describing this as passing through the dividend's economic benefit, while maintaining that no shareholder dividend right exists. The two statements are not contradictory, but a reader should not take "no dividend rights" to mean no economic adjustment at all, nor take "dividend economics passed through" to mean a cash dividend is paid. In Oura's case the company does not currently expect to pay a dividend, which narrows the practical difference for now without changing the legal one.

As with any product tracking an equity, OURAx carries the underlying risk that Oura's share price falls after listing, on top of risks specific to the wrapper: whether Backed Assets (JE) Limited meets its obligations as issuer, how securely the underlying shares are held in custody, whether OURAx can be sold quickly at a fair price, whether its price tracks Oura's Nasdaq price accurately, and the operational risks of the blockchain infrastructure it runs on. The identity of the custodian holding the specific shares backing OURAx was not stated in Payward's announcement; Kraken's general xStocks FAQ names two custodians used for xStocks generally, but that does not confirm which one, if either, holds the Oura shares.

Why Britain is outside the offer

None of Payward's or Kraken's public pages point to a specific Financial Conduct Authority (FCA) order or a UK statute naming xStocks or OURAx. What Payward says, more generally, is that xStocks are not offered where distribution would be unlawful or would require an authorisation it has not obtained. That is a description of a compliance decision, not confirmation of a blanket UK prohibition on tokenised securities as a category.

The FCA's own guidance backs that reading. Its handbook guidance on regulated cryptoasset activities, updated 16 September 2026, says a cryptoasset's regulatory status turns on its legal and economic substance rather than its label or the technology used to issue it — and gives tokenised shares and tokenised debt securities as examples of instruments that can fall within the UK regulatory perimeter as specified investments. The FCA's cryptoassets work page, published 30 June 2026, adds that a token amounting to a specified investment is likely to sit inside that perimeter and can trigger the UK's established securities and financial-promotion rules, separately from the newer cryptoasset-specific regime.

Two UK regimes already reach into this area. The financial-promotion rules for qualifying cryptoassets have applied to firms marketing to UK consumers, including overseas firms, since 8 October 2023. Where a token is instead classified as a specified investment — which a tokenised debt security plausibly could be — the pre-existing securities and promotion framework applies rather than, or alongside, the cryptoasset-specific rules. Whether OURAx would in fact be classified as a specified investment, and what permissions a firm would need to distribute it lawfully to UK retail customers, cannot be settled from marketing pages; it would depend on the token's final legal terms, its distribution route and the activities carried out in Britain. No source reviewed for this article shows the FCA has assessed OURAx specifically.

What Britain is building, and what it isn't yet

The UK has an official route for testing tokenised market infrastructure: the Digital Securities Sandbox, established by regulations that came into force on 8 January 2024 following a statutory instrument laid before Parliament on 18 December 2023. It allows approved firms to test digital-securities infrastructure under temporarily modified rules. That demonstrates an institutional route toward UK tokenisation; it does not, on its own, make an offshore retail product like xStocks available to UK customers, and OURAx remains excluded regardless.

Separately, the FCA's wider package of cryptoasset rules, published in final form on 30 June 2026, is scheduled to apply to firms authorised under the Financial Services and Markets Act from 25 October 2027. The FCA has said that cryptoassets which are specified investments will initially continue to be held under the existing CASS 6 custody rules rather than the new CASS 17 regime built for cryptoassets generally. That 2027 start date is a future milestone for authorised UK firms, not an explanation for today's exclusion, and readers should not treat it as the reason OURAx is unavailable now.

None of this implies Financial Services Compensation Scheme or Financial Ombudsman Service protection for OURAx or any comparable tokenised product; no source used for this article establishes that either scheme would apply, and a reader should not assume cover exists.

What to watch next

Oura's pricing, on 29 September 2026, and its Nasdaq listing, expected the following day, were both still pending as of the research date and should be checked against the SEC's filings and Nasdaq's own notices once they occur. The final terms of OURAx, including its identifier and confirmed custodian, had not been published. Any UK-specific authorisation step by Payward, or FCA guidance addressing xStocks or comparable tokenised-share products by name, would materially change this picture and should be checked at the FCA's website before drawing further conclusions.